Eric Miller, MD, PhD, principal investigator of the trial and associate professor of radiation oncology at The Ohio State University Comprehensive Cancer Center (IMAGE)
Caption
“This milestone reflects the commitment of patients, clinicians, and research teams across the country to answer a question that has major implications for how we treat metastatic colorectal cancer,” said Eric Miller, MD, PhD, principal investigator of the trial and associate professor of radiation oncology at The Ohio State University Comprehensive Cancer Center. “If successful, ERASur could help redefine the role of aggressive local therapy beyond liver-only metastases.”
Credit
The Ohio State University Comprehensive Cancer Center
Usage Restrictions
none
License
Original content